ASEAN Medicine Trade Barriers Lowered

BMI expects more drugmakers in South East Asia to get Good Manufacturing Practice (GMP) accreditation after a major trade agreement was signed. Upgrading facilities and processes will require considerable investment in the short term, but producers of pharmaceuticals will eventually see a significant upside, both domestically and abroad. This is because consumers, especially those on those low incomes, will increasingly appreciate the quality of medicines made in the region.

To read the full article, please sign in or take a free trial.